![PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors](https://i1.rgstatic.net/publication/335436307_Death_after_hematopoietic_stem_cell_transplantation_changes_over_calendar_year_time_infections_and_associated_factors/links/5d65d35e299bf1f70b124199/largepreview.png)
PDF) Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors
![PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT)](https://i1.rgstatic.net/publication/336712884_Benchmarking_of_survival_outcomes_following_haematopoietic_stem_cell_transplantation_A_review_of_existing_processes_and_the_introduction_of_an_international_system_from_the_European_Society_for_Blood_/links/5daeb2eb299bf111d4bfa849/largepreview.png)
PDF) Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT)
![Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-019-0718-7/MediaObjects/41409_2019_718_Fig5_HTML.png)
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and
![Bertrand Delsuc na Twitteru: "C Chabannon - PASS and PAES: The need for registration, short- and long-term follow-up of patients treated with gene therapy medicinal products #CART2020 5/x https://t.co/QJmrNeFIAH" / Twitter Bertrand Delsuc na Twitteru: "C Chabannon - PASS and PAES: The need for registration, short- and long-term follow-up of patients treated with gene therapy medicinal products #CART2020 5/x https://t.co/QJmrNeFIAH" / Twitter](https://pbs.twimg.com/media/EPoIkjVXsAEAiH8.png)
Bertrand Delsuc na Twitteru: "C Chabannon - PASS and PAES: The need for registration, short- and long-term follow-up of patients treated with gene therapy medicinal products #CART2020 5/x https://t.co/QJmrNeFIAH" / Twitter
![Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions](https://pub.mdpi-res.com/cancers/cancers-13-05827/article_deploy/html/images/cancers-13-05827-g001.png?1637403045)
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
![View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment](https://journals.aboutscience.eu/index.php/grhta/article/download/2340/2522/9010/img04.png)
View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment
Dipropinonates of Sugar Alcohols as Water-Soluble, Nontoxic CPAs for DMSO-Free Cell Cryopreservation | ACS Biomaterials Science & Engineering
![Cells | Free Full-Text | Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches Cells | Free Full-Text | Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches](https://pub.mdpi-res.com/cells/cells-11-03346/article_deploy/html/images/cells-11-03346-g001.png?1666608384)
Cells | Free Full-Text | Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
![View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment View of Use of a maturity model for facilitating the introduction of CAR T-cell therapy—Results of the START CAR-T project | Global & Regional Health Technology Assessment](https://journals.aboutscience.eu/index.php/grhta/article/download/2340/2522/9008/img02.png)